Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fortitech Asia Pacific is a regional division of Fortitech, a global leader in the development and manufacture of custom nutrient premixes for the food, beverage, and pharmaceutical industries. Acquired by DSM (now dsm-firmenich) in 2012, the company specializes in creating tailored blends of vitamins, minerals, amino acids, nucleotides, and botanicals designed to enhance the nutritional profile of consumer products. Their services include formulation assistance, stability testing, and technical support to ensure the efficacy and quality of the final product. Operating from a state-of-the-art facility in Malaysia, they serve as a strategic hub for the Asia-Pacific market, providing high-quality, food-grade, and pharmaceutical-grade ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fortitech Asia Pacific.